Company research / RDNT

RadNet, Inc. (RDNT)

CIK 0000790526 · Nasdaq · Services-Medical Laboratories

  • Sector Services
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, RadNet, Inc. reported revenue of $2.04B. Revenue grew 11.5% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $2.27B.

Key ratios (year ended 2025-12-31)

3.0%
Operating margin
-0.9%
Net margin
-1.4%
Return on year-end equity
11.5%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 8-K (current report) · 2026-08-14

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30
2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$2.27B$2.04B$1.83B$1.62B$1.43B$1.32B$1.07B$1.15B$975.15M$922.19M$884.53M
Cost of Revenuen/an/an/an/an/an/an/a$999.69M$867.55M$802.38M$775.80M
Gross Profit (computed)n/an/an/an/an/an/an/a$154.49M$107.60M$119.81M$108.73M
Operating Income$70.78M$61.99M$104.62M$98.70M$46.36M$82.55M$35.68M$69.88M$30.89M$50.05M$38.48M
Depreciation & Amortizationn/a$136.10M$125.30M$116.20M$105.60M$92.30M$83.10M$77.50M$70.20M$64.20M$64.00M
EBITDAn/a$198.09M$229.92M$214.90M$151.96M$174.85M$118.78M$147.38M$101.09M$114.25M$102.48M
Net Income-$21.12M-$18.65M$2.79M$3.04M$10.65M$24.73M-$14.84M$14.76M$32.24M$53.0K$7.23M
EPS (Diluted)n/a-$0.25$0.04$0.05$0.17$0.46-$0.29$0.29$0.66$0.00$0.15
Total Assets$4.23B$3.76B$3.29B$2.69B$2.43B$2.06B$1.79B$1.65B$1.11B$868.98M$849.48M
Total Liabilities$2.83B$2.40B$2.15B$1.88B$1.94B$1.71B$1.53B$1.41B$909.08M$799.05M$797.42M
Long-Term Debt$1.33B$1.09B$1.02B$830.04M$851.74M$754.66M$652.70Mn/an/a$575.04M$612.17M
Shareholders' Equity$1.39B$1.36B$1.13B$813.36M$491.45M$346.16M$258.30M$233.14M$200.25M$69.92M$52.05M
Cash & Equivalents$726.27M$767.22M$740.02M$342.57M$127.83M$134.61M$102.02M$40.16M$10.39M$51.32M$20.64M
Operating Cash Flow$310.06M$298.82M$233.02M$220.86M$146.42M$149.49M$233.76M$104.32M$116.75M$142.22M$91.64M
Capital Expendituresn/an/an/an/an/an/an/a$74.15M$72.18M$61.34M$59.25M
Free Cash Flown/an/an/an/an/an/an/a$30.17M$44.57M$80.89M$32.39M
Shares Outstanding78.65M74.04M74.04M67.96M57.72M53.55M51.64M50.31M48.98M47.72M46.57M
Weighted Average Diluted Sharesn/a75.19M74.76M64.66M57.32M53.42M50.89M50.24M48.68M47.40M46.66M
EPS (Basic)n/a-$0.25$0.04$0.05$0.19$0.47-$0.29$0.30$0.67$0.00$0.16

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView